JAZZ - CIK 0001232524
The table below shows Jazz Pharmaceuticals plc's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.84B | $1.33B | $1.19B | $1.86B | $2.22B | $1.36B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $836.30M | $764.36M | $714.00M | $652.99M | $723.64M | $698.04M |
| Inventory | $437.50M | $483.11M | $504.99M | $492.78M | $539.30M | $542.55M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $4.58B |
| $3.76B |
| $3.35B |
| $4.13B |
| $4.39B |
| $3.68B |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $1.80B | $1.83B | $1.84B | $1.76B | $1.80B | $1.74B |
| Total assets | $11.86B | $11.36B | $10.94B | $11.53B | $12.26B | $11.36B |
| Accounts payable | $100.00M | $152.23M | $89.37M | $95.93M | $85.42M | $97.10M |
| Total current liabilities | $2.25B | $2.27B | $2.07B | $1.22B | $1.03B | $1.56B |
| Long-term debt | $4.32B | $4.33B | $4.34B | $5.34B | $6.08B | $5.10B |
| Total liabilities | - | - | - | - | - | - |
| Retained earnings | $939.20M | $442.73M | $191.31M | $1.03B | $936.23M | $871.18M |
| Total equity | $4.53B | $3.96B | $3.71B | $4.17B | $4.17B | $3.76B |